Search

Author/Creator Burstein, Rami

42. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. Issue 11 (November 2015)

Authors:
Bigal, Marcelo E; Edvinsson, Lars; Rapoport, Alan M; Lipton, Richard B; Spierings, Egilius L H; Diener, Hans-Christoph; Burstein, Rami; Loupe, Pippa S; Ma, Yuju; Yang, Ronghua; Silberstein, Stephen D
Journal:
Lancet neurology
Issue:
Volume 14:Issue 11(2015:Nov.)
Page Start:
1091
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

43. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. Issue 11 (November 2015)

Authors:
Bigal, Marcelo E; Dodick, David W; Rapoport, Alan M; Silberstein, Stephen D; Ma, Yuju; Yang, Ronghua; Loupe, Pippa S; Burstein, Rami; Newman, Lawrence C; Lipton, Richard B
Journal:
Lancet neurology
Issue:
Volume 14:Issue 11(2015:Nov.)
Page Start:
1081
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

50. The migraine eye: distinct rod-driven retinal pathways' response to dim light challenges the visual cortex hyperexcitability theory. Issue 3 (March 2019)

Authors:
Bernstein, Carolyn A.; Nir, Rony-Reuven; Noseda, Rodrigo; Fulton, Anne B.; Huntington, Shaelah; Lee, Alice J.; Bertisch, Suzanne M.; Hovaguimian, Alexandra; Buettner, Catherine; Borsook, David; Burstein, Rami
Journal:
Pain
Issue:
Volume 160:Issue 3(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗